Bioscience industry stakeholder collaboration key to addressing inequality
Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you have a voice that should be heard? Reach out to Amber Tong.
When a global pandemic hit, the bioscience industry answered the call for vaccines and therapies in record time, which will save millions of lives. This response was possible because of a sustained investment of risk-capital by the venture capital industry in life sciences companies, peaking in 2020. Great scientists, visionary leadership and high-quality investors that backed new science and bold entrepreneurs led to the innovative technologies of BioNTech and Moderna that contributed to the initial Covid-19 vaccines.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.